Docetaxel
Back to searchMolecule Structure
Scientific Name
Docetaxel
Description of the Drug
Docetaxel is a taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01248
http://www.drugbank.ca/drugs/DB01248
Brand Name(s)
Not Available
Company Owner(s)
Amneal Eu Ltd, Jiangsu Hengrui Pharmaceuticals Co Ltd, Ingenus Pharmaceuticals Llc, Pfizer Labs, Hospira Inc, Accord Healthcare Inc, Actavis Llc An Indirect Wholly-Owned Sub Of Teva Pharmaceuticals Usa Inc, Dfb Oncology Ltd, Mylan Laboratories Ltd, Hikma Farmaceutica Portugal Sa
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Tubulin | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2095182 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4419 | |||
PharmGKB | PA449383 | |||
Human Metabolome Database | HMDB0015378 | |||
DrugBank | DB01248 | |||
PubChem: Thomson Pharma | 14815974 | 14791415 | ||
PubChem | 148124 | |||
Mcule | MCULE-1930158681 | |||
NMRShiftDB | 20165114 | |||
LINCS | LSM-6360 | |||
Nikkaji | J314.049K | |||
PDBe | TXL | |||
BindingDB | 36351 | |||
EPA CompTox Dashboard | DTXSID0040464 | |||
DrugCentral | 939 | |||
Brenda | 139427 | |||
Guide to Pharmacology | 6809 | |||
rxnorm | DOCETAXEL | DOCEFREZ | TAXOTERE | DOCETAXEL ANHYDROUS |
PubChem: Drugs of the Future | 12014196 | |||
KEGG Ligand | C11231 | |||
ChEBI | 4672 | |||
ZINC | ZINC000085537053 |